Street Poller Media and The Boom of the Street Interview Ad Industry 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Toyota Global Sales Fall as China Demand Slumps 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Add as a preferred source on Google
MENLO PARK, Calif., April 17, 2018 -- Geron Corporation (Nasdaq:GERN) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018, at 4:00 p.m. PDT.
Geron’s stockholders are invited to attend the Annual Meeting in person at the company’s offices located at 149 Commonwealth Drive, Menlo Park, California 94025 or by conference call by dialing 877-303-9139 (U.S.) or 760-536-5195 (international). The conference ID is 7197767 or 68816558. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. Participants attending in person and by conference call will have an opportunity to ask questions during the meeting. In addition, stockholders may submit questions in advance of the meeting to the email address: [email protected]. A live audio-only webcast will also be available through the Investors section of Geron’s website at www.geron.com. The audio webcast of the Annual Meeting will be available for replay approximately one hour following the live broadcast through June 16, 2018.
First Quarter 2018 Financial Results Announcement Date
Geron will announce its financial results for the first quarter ended March 31, 2018 on Thursday, May 10, 2018, after the market close. Due to the proximity of the company’s Annual Meeting, Geron will not be hosting a separate first quarter conference call.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
[email protected]
[email protected]
